Monday

20th Feb 2017

EU ponders swine flu vaccine glut

  • Swine flu is thought to have originated in Mexico (Photo: Eneas De Troya)

The outbreak of swine flu in North America last April and subsequent spread around the globe lead the World Health Organisation to rapidly raise its pandemic alert warnings in the following weeks, reaching a maximum Phase Six on 11 June 2009.

But now, less than a year later, several EU countries find themselves among a list of states with an excessive stockpile of a hastily-made vaccine, leading to accusations of misspent taxpayer money and collusion between the WTO and private pharmaceutical companies.

Dear EUobserver reader

Subscribe now for unrestricted access to EUobserver.

Sign up for 30 days' free trial, no obligation. Full subscription only 15 € / month or 150 € / year.

  1. Unlimited access on desktop and mobile
  2. All premium articles, analysis, commentary and investigations
  3. EUobserver archives

EUobserver is the only independent news media covering EU affairs in Brussels and all 28 member states.

♡ We value your support.

If you already have an account click here to login.

The French administration, for example, ordered enough vaccine to inoculate its entire population of 60 million, but has so far used only 5 million doses. It now hopes to cancel 50 million doses and sell millions more.

The Netherlands is looking to sell 19 million doses to other countries, while Germany is in talks with drug manufacturers to halve its order of 50 million doses. Switzerland, Spain and Britain are also considering plans to sell excess supplies.

A review process analysing Europe's effectiveness in tackling the health crisis last year, and involving the European Commission and member states, will look into the causes of the vaccine glut, amongst other issues. Initiated towards the end of December, the results are set to be submitted under the Belgian EU presidency in the second half of 2010.

With health issues still largely a national competence, commission officials say their role in the early days of the outbreak was to facilitate information exchange between European capitals, with efforts now concentrating on the need to redistribute the surplus vaccines.

The EU executive body will not comment on allegations of collusion, pointing instead to the initial mistaken belief that individuals would need two vaccine doses to acquire immunity as the main reason for the vaccine glut in certain states.

Council of Europe

The Strasbourg-based Council of Europe, a non-EU institution dealing primarily with human rights issues and made up of national MPs, held a public hearing on the subject however on 26 January, with the question up for debate: "Are decisions on pandemics taken on the best scientific evidence only?"

Dr Wolfgang Wodarg, a specialist in epidemiology and former member of the Council's assembly until he lost his seat in the September German elections, accuses the WTO of providing governments with poor information. He notes that the strain's transmissibility was used to define pandemic status, with no consideration given to the severity of the strain.

The former German politician also highlighted during the public hearing that the WTO's definition of a pandemic was changed as recently as last May, with the decision to purchase vaccines in several capitals triggered by the WTO issuing its pandemic warning.

"It was only this change of definition that made it possible to transform a run-of-the-mill flu into a worldwide pandemic – and made it possible for the pharmaceutical industry to transform this opportunity into cash, under contracts which were mainly secret," he told attendees.

Dr Keiji Fukuda, special advisor on pandemic influenza to the WHO's director-general, defended the organisation's action during the last year's outbreak.

"The flu pandemic policies and responses were not improperly influenced by the pharmaceutical industry. Co-operation with a range of partners, including the private sector, is necessary, but numerous safeguards are in place to avoid conflict of interest," he said.

He added that labeling the pandemic as a "fake" would be to ignore recent history and science and to trivialise the deaths of over 14,000 people that have taken place so far as a result of the virus.

The subject has now been taken up by Council Assembly member and UK Labour MP Paul Flynn, with a report expected in June. The European Commission says it will react to the report once published.

EUobserver's special focus section delves into the challenges confronting healthcare, this most cherished element of the European welfare state. See more: Health Focus

Tuberculosis' deadly return to Europe

Experts worry that Europe, which spent millions battling a Swine flu that killed 14,000 last year, is at a loss when dealing with the threat from the more mundane but far more lethal tuberculosis, which strikes down 1.77 million people annually.

Focus

Ageing Europe forcing change to EU health services

Europe is steadily greying. Already the oldest continent in the world, figures for the EU's 27 member states show that by 2060, the ratio of people of working age to those over age 65 will be two to one while the over 80s is likely to be the fastest growing segment. The changing demographics have profound implications for health services across the EU.

Medical staff exodus takes toll on new member states

The free movement of doctors and mutual recognition of medical degrees across the EU is fueling an East-West migration, at the expense of already under-staffed and underpaid medical systems in new member states.

EU ponders swine flu vaccine glut

The outbreak of swine flu in North America last April and subsequent spread around the globe lead the World Health Organisation to rapidly raise its pandemic alert warnings in the following weeks, reaching a maximum Phase Six on 11 June 2009. But now, less than a year later, several EU countries find themselves among a list of states with an excessive stockpile of a hastily-made vaccine.

Focus

Hurdles confront e-health across Europe

Information technology applied to healthcare – broadly termed e-health – is set to revolutionise patient care and how healthcare systems can be structured and managed. However, different obstacles are standing in the way for Europe to truly embrace the digital reform of its healthcare systems.

News in Brief

  1. Migrants storm Spanish enclave of Ceuta
  2. Spain's princess fined for tax fraud, husband sentenced
  3. EU to invest millions in energy infrastructure
  4. Dutch data watchdog forces online vote aides to up security
  5. EU allows Lithuania to ban Russian tv channel
  6. Finland announces increase in defence spending
  7. Ex-PM Blair says Brits should 'rise up' against Brexit
  8. Nato chief says facts to prevail over fake news

Stakeholders' Highlights

  1. Malta EU 2017End of Roaming Fees: Council Reaches Agreement on Wholesale Caps
  2. Nordic Council of MinistersNordic Innovation House Opens in New York to Help Startups Access US Market
  3. Centre Maurits CoppietersMinorities and Migrations
  4. Salzburg Global SeminarThe Child in the City: Health, Parks and Play
  5. UNICEFNumber of Ukrainian Children Needing Aid Nearly Doubles to 1 Million Over the Past Year
  6. Centre Maurits CoppietersThe Situation of Refugee Women in Europe
  7. Salzburg Global SeminarToward a Shared Culture of Health: Charting the Patient-Clinician Relationship
  8. European Free AllianceAustria Should Preserve & Promote Bilingual and Multinational Carinthia
  9. Martens CentreShow Your Love for Democracy! Take Part in Our Contest: "If It's Broken, Let's Fix It"
  10. CISPECloud Computing Leaders Establish Data Protection Standards to Protect Customer Data
  11. Malta EU 2017Landmark Deal Reached With European Parliament on Portability of Online Content
  12. Belgrade Security ForumBSF 2017: Building a Common Future in the Age of Uncertainty